Showing results (1591-1600 of 1,700) with videos related to
Sort By:
Pageof 170
JAMA Cardiology|June 29, 2017
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Rafael Harari, Usman Baber, et al.The New England Journal of Medicine|August 28, 2018
One-Year Outcomes after PCI Strategies in Cardiogenic ShockHolger Thiele, Ibrahim Akin, Marcus Sandri, et al.The Annals of Thoracic Surgery|October 7, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsRebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.JACC. Cardiovascular Interventions|September 24, 2016
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Ioannis Mastoris, Usman Baber, et al.Journal of the American College of Cardiology|October 7, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsRebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.European Heart Journal|October 4, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsRebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.American Heart Journal|February 1, 2019
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) StudyEnrico Frigoli, Pieter Smits, Pascal Vranckx, et al.Circulation. Cardiovascular Interventions|July 11, 2019
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsUsman Baber, Giulio G Stefanini, Gennaro Giustino, et al.Lancet (London, England)|September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.Pageof 170